The Department of Health – Abu Dhabi hosted a panel discussion titled “Thalassemia in the Middle East and North Africa" at Arab Health 2025. The session highlighted the significant progress in treating thalassemia in the UAE, international collaboration to provide the latest treatment options for patients in the region, and the Department’s role in driving scientific research and clinical trials for innovative medicines that can enhance patient quality of life. The session also discussed the new guidelines for the management of Transfusion-Dependent -Thalassaemia (TDT), which serve as a key reference for practitioners worldwide in the care of this condition, underscoring the role of international collaboration in improving healthcare outcomes and solidifies the Emirate's position as a leading hub for healthcare and life sciences. Speakers included: - Dr. Mohamed Alameri, PhD, AFHEA - Section Head Studies and Special Projects at DoH - Prof. Ali Taher, MD, PhD, FRCP - Director, Naef K. Basile Cancer Institute at the American University of Beirut - Prof. Khaled Musallam, MD, PhD - Group Chief Research Officer for Burjeel Holdings - Shakeela Bashir Ahmed – Head of Communication at the Emirates Thalassemia Society #ArabHealth #ArabHealth2025 #AHealthierAbuDhabi #Healthcare #Innovation
Fazal Vakhab
2mo
Great work, whenever I deal and see transfusion dependant child with suffering its broken our hearts and the suffering of parents is another sorrow. UAE is leading leader in health and such activities bring change and opening doors for moving forward. Keep it up. May Allah bless you all.
Amazing 👏
Department of Health Abu Dhabi , It's inspiring to see such important discussions happening around thalassemia treatment! The focus on collaboration and new guidelines is crucial for improving patient care. Kudos to everyone involved in this initiative! What are some of the key takeaways from the panel that you think will have the biggest impact? 🌍💡 #Thalassemia #HealthcareInnovation